SEC Filing Summary: Colony NorthStar, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Colony NorthStar, Inc. on January 19, 2017. The filing details the completion of a material asset disposition involving the company's healthcare real estate portfolio.
Key Financial Metrics and Transaction Details
- Transaction Value: $350,000,000 (including $20,000,000 of pre-funded capital items).
- Asset Sold: An 18.7% interest in the Healthcare Portfolio.
- Implied Portfolio Valuation: Approximately $5.4 billion for the Healthcare Properties (excluding $0.8 billion of medical office buildings sold previously).
- Portfolio Composition: 191 senior housing properties, 113 medical office properties, 14 hospitals, and 107 skilled nursing facilities.
- Ownership Structure Post-Transaction:
- Derwood Limited: 18.7% interest in the Joint Venture (approx. 16.4% aggregate ownership of Healthcare Properties).
- CLNS Partner (Colony NorthStar): 81.3% interest in the Joint Venture (approx. 71.3% aggregate ownership of Healthcare Properties).
- Existing Minority Interest Holders: Approx. 12.3% aggregate ownership.
Material Changes
The primary material change is the entry into a definitive agreement and the subsequent completion of the sale of a partial interest in the Healthcare Portfolio to Derwood Limited. This transaction establishes a new joint venture structure where Colony NorthStar retains majority control and management responsibilities while monetizing a portion of its equity.
Outlook, Risks, and Contingencies
The filing references pro forma financial information for the nine months ended September 30, 2016, and the year ended December 31, 2015, available in Exhibit 99.1. The Company agreed to customary indemnifications subject to caps and limitations. The filing does not provide specific forward-looking guidance, risk factors, or management commentary beyond the transaction mechanics and the reference to the Purchase Agreement.
Investor Verification Checklist
- Review the full Purchase and Sale Agreement (Exhibit 10.1) for specific covenants, indemnification caps, and termination rights.
- Analyze the Unaudited Pro Forma Condensed Consolidated Financial Statements (Exhibit 99.1) to understand the impact on earnings and balance sheet metrics.
- Verify the operational structure of the new Joint Venture and the extent of Colony NorthStar's retained management fees or profit participation.
- Confirm the status of the $20,000,000 pre-funded capital items and their accounting treatment.